Qualigen Therapeutics Inc QLGN

NAS: QLGN | ISIN: US74754R1032 27/05/2025

3,650 USD (-3,27%)

(-3,27%) 27/05/2025

Grafiek Qualigen Therapeutics Inc

Grafiek Qualigen Therapeutics Inc

1 dag1d -3,27%
1 week1w -2,93%
1 maand1m 3,99%
3 maanden3m 15,14%
6 maanden6m -20,95%
1 jaar1j 1.194,33%
5 jaar5j -42,97%

Qualigen Therapeutics Inc in het nieuws

Toon enkel gratis nieuws

18 maart 2021 · Qualigen Therapeutics, Inc. to present at the Benzinga Biotech Small Cap Conference · Persbericht

8 maart 2021 · Qualigen Therapeutics, Inc. to present at the Oppenheimer 31st Annual Healthcare Conference · Persbericht

1 maart 2021 · Qualigen Therapeutics Secures Option to Negotiate License for G-Quadruplex Anti-Cancer Technology from UCL · Persbericht

26 januari 2021 · Qualigen Therapeutics Announces Completion of Milestone Related to the License and Technology Transfer of its FastPack® Diagnostics Products in China · Persbericht

5 januari 2021 · Qualigen Therapeutics to Present at the H.C. Wainwright BioConnect 2021 Conference · Persbericht

Profiel Qualigen Therapeutics Inc

Fabricage van farmaceutische preparaten

Farmaceutische producten: Andere

Gezondheidstechnologie

Medische Specialiteiten

Website: www.qualigeninc.com

Hoofdzetel: Los Angeles, California Verenigde Staten

CEO: Andrew Ritter

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe